SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001513160-14-000076
Filing Date
2014-12-10
Accepted
2014-12-10 16:52:35
Documents
11
Period of Report
2013-03-31

Document Format Files

Seq Description Document Type Size
1 OXIS INTERNATIONAL QUARTERLY REPORT oxis10q033113.htm 10-Q 486656
2 CERTIFICATION SECTION 302 ex311.htm EX-31.1 12559
3 CERTIFICATION SECTION 302 ex312.htm EX-31.2 11258
4 CERTIFICATION SECTION 906 ex321.htm EX-32.1 5709
5 CERTIFICATION SECTION 906 ex322.htm EX-32.2 6001
  Complete submission text file 0001513160-14-000076.txt   2312843

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT oxis-20130331.xml EX-101.INS 228018
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT oxis-20130331.xsd EX-101.SCH 19379
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT oxis-20130331_cal.xml EX-101.CAL 35070
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT oxis-20130331_def.xml EX-101.DEF 43522
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT oxis-20130331_lab.xml EX-101.LAB 152244
11 XBRL TAXONOMHY EXTENSION PRESENTATION LINKBASE DOCUMENT oxis-20130331_pre.xml EX-101.PRE 113374
Mailing Address 468 N. CAMDEN DR. 2ND FLOOR BEVERLY HILLS CA 90210
Business Address 468 N. CAMDEN DR. 2ND FLOOR BEVERLY HILLS CA 90210 (310) 551-4020
OXIS INTERNATIONAL INC (Filer) CIK: 0000109657 (see all company filings)

IRS No.: 941620407 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-08092 | Film No.: 141278564
SIC: 2834 Pharmaceutical Preparations